Principal Financial Group
KURA icon

Principal Financial Group’s Kura Oncology KURA Stock Holding History

Principal Financial Group’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-12,492
Closed -$257K – 2322
2024
Q2 		$257K Sell
12,492
-5,299
-30% -$109K ﹤0.01% 2089
2024
Q1 		$379K Sell
17,791
-1,578
-8% -$30.7K ﹤0.01% 2045
2023
Q4 		$279K Sell
19,369
-2,095
-10% -$20.6K ﹤0.01% 2078
2023
Q3 		$196K Buy
21,464
+3,877
+22% +$39.4K ﹤0.01% 2171
2023
Q2 		$186K Buy
17,587
+401
+2% +$4.74K ﹤0.01% 2194
2023
Q1 		$210K Buy
17,186
+2,572
+18% +$32.1K ﹤0.01% 2172
2022
Q4 		$181K Buy
14,614
+358
+3% +$5.2K ﹤0.01% 2216
2022
Q3 		$195K Buy
14,256
+3,468
+32% +$53.5K ﹤0.01% 2211
2022
Q2 		$198K Buy
+10,788
New +$155K ﹤0.01% 2301
2021
Q4 		– Sell
-13,154
Closed -$246K – 2588
2021
Q3 		$246K Sell
13,154
-2,131
-14% -$40.2K ﹤0.01% 2371
2021
Q2 		$319K Sell
15,285
-10,760
-41% -$267K ﹤0.01% 2336
2021
Q1 		$737K Sell
26,045
-1,258
-5% -$39.8K ﹤0.01% 2058
2020
Q4 		$892K Buy
27,303
+9,595
+54% +$337K ﹤0.01% 1967
2020
Q3 		$542K Buy
+17,708
New +$391K ﹤0.01% 2009

Other funds holding KURA

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Principal Financial Group's KURA Position: Q3 2024 in Review

Principal Financial Group sold out of Kura Oncology (KURA) in Q3 2024, closing a stake of 12,492 shares — an estimated $257K sold.

Principal Financial Group first reported a position in KURA in Q3 2020 and held it in 14 quarters. The position peaked at $892K in Q4 2020. 179 funds tracked by Wall St. Rank hold KURA as of Q3 2024.

  • Principal Financial Group reported no remaining Kura Oncology position as of Q3 2024 after selling out during the quarter.
  • Principal Financial Group sold 12,492 Kura Oncology shares in Q3 2024, an estimated $257K.
  • Principal Financial Group first reported a position in Kura Oncology in Q3 2020 and held it in 14 quarters.
  • Principal Financial Group's Kura Oncology position peaked at $892K in Q4 2020.
  • 179 funds tracked by Wall St. Rank held Kura Oncology as of Q3 2024.

Based on Principal Financial Group's 13F filing for Q3 2024, filed 31 Oct 2024.